retatrutide pros and cons – The New Weight Loss Helper Retatrutide is a new medication being developed by Eli Lilly to help people lose weight. It's like a super version of drugs such as Ozempic Retatrutide, an experimental weight-loss drug,

Final availability depends on the patients state, provider decision, pharmacy assignment and chosen treatment term

For now, elecoglipron remains investigational

Patients should avoid these in favor of physician-prescribed, FDA-approved therapies

A recent case report of a woman who was diagnosed with MTC while on a GLP-1 agonist showed no change in her calcitonin levels ( Gastroenterology

GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists These agents are commonly used therapies for managing diabetes and obesity, but gastrointestinal adverse effects such as nausea, vomiting, diarrhea, and constipation frequently limit therapy

PMC 4912689